Page 114 - 中国药房2023年10期
P. 114

综上所述,极早产儿早期预防性使用小剂量 HC 可                             pulmonary  dysplasia:a  multicenter  trial[J].  Pediatrics,
          减少 BPD 的发生,降低病死率,提高无 BPD 生存率,但                           2004,114(6):1649-1657.
          需注意胃肠道穿孔和败血症的发生。本研究的局限性                             [12]  ALISON M,TILEA B,TOUMAZI A,et al. Prophylactic
          为:(1)HC 使用的疗程多样,对照组干预措施不统一;                              hydrocortisone  in  extremely  preterm  infants  and  brain
         (2)纳入的文献数量相对较少,且部分文献样本量较                                  MRI  abnormality[J]. Arch  Dis  Child  Fetal  Neonatal  Ed,
          小。故所得结论有待更多大样本、多中心的 RCT 予以                               2020,105(5):520-525.
                                                              [13]  BAUD  O,MAURY  L,LEBAIL  F,et  al.  Effect  of  early
          验证。
                                                                   low-dose hydrocortisone on survival without bronchopul‐
          参考文献
                                                                   monary   dysplasia   in   extremely   preterm   infants
          [ 1 ]  HIGGINS  R  D,JOBE A  H,KOSO-THOMAS  M,et  al.
                                                                  (PREMILOC):a double-blind,placebo-controlled,multi‐
               Bronchopulmonary  dysplasia:executive  summary  of  a
                                                                   centre,randomised  trial[J].  Lancet,2016,387(10030):
               workshop[J]. J Pediatr,2018,197:300-308.
                                                                   1827-1836.
          [ 2 ]  STOLL  B  J,HANSEN  N  I,BELL  E  F,et  al. Trends  in
                                                              [14]  BONSANTE  F,LATORRE  G,IACOBELLI  S,et  al.
               care  practices,morbidity,and  mortality  of  extremely
                                                                   Early low-dose hydrocortisone in very preterm infants:a
               preterm neonates,1993-2012[J]. JAMA,2015,314(10):
                                                                   randomized,placebo-controlled trial[J]. Neonatology,2007,
               1039-1051.
                                                                   91(4):217-221.
          [ 3 ]  TWILHAAR E S,WADE R M,DE KIEVIET J F,et al.
                                                              [15]  BOURCHIER  D,WESTON  P  J.  Randomised  trial  of
               Cognitive  outcomes  of  children  born  extremely  or  very
                                                                   dopamine compared with hydrocortisone for the treatment
               preterm  since  the  1990s  and  associated  risk  factors:a
                                                                   of hypotensive very low birthweight infants[J]. Arch Dis
               meta-analysis  and  meta-regression[J].  JAMA  Pediatr,
                                                                   Child Fetal Neonatal Ed,1997,76(3):F174-F178.
               2018,172(4):361-367.
                                                              [16]  EFIRD  M  M,HEERENS A  T,GORDON  P  V,et  al. A
          [ 4 ]  BHANDARI  V.  Postnatal  inflammation  in  the  patho-
                                                                   randomized-controlled  trial  of  prophylactic  hydrocor-
               genesis  of  bronchopulmonary  dysplasia[J].  Birth  Defects
               Res A Clin Mol Teratol,2014,100(3):189-201.         tisone supplementation for the prevention of hypotension
          [ 5 ]  DELARA  M,CHAUHAN  B  F,LE  M  L,et  al.  Efficacy   in extremely low birth weight infants[J]. J Perinatol,2005,
                                                                   25(2):119-124.
               and safety of pulmonary application of corticosteroids in
               preterm infants with respiratory distress syndrome:a sys‐  [17]  HOCHWALD  O,PALEGRA  G,OSIOVICH  H.  Adding
               tematic review and meta-analysis[J]. Arch Dis Child Fetal   hydrocortisone as 1st line of inotropic treatment for hypo‐
               Neonatal Ed,2019,104(2):F137-F144.                  tension in very low birth weight infants[J]. Indian J Pedi‐
          [ 6 ]  PHAROAH  P  D.  Dexamethasone  treatment  and  cerebral   atr,2014,81(8):808-810.
               palsy[J]. Arch Dis Child Fetal Neonatal Ed,2001,84(2):  [18]  PARIKH N A,KENNEDY K A,LASKY R E,et al. Pilot
               140Fa-140.                                          randomized trial of hydrocortisone in ventilator-dependent
          [ 7 ]  HALLIDAY  H  L.  Early  postnatal  dexamethasone  and      extremely  preterm  infants:effects  on  regional  brain
               cerebral palsy[J]. Pediatrics,2002,109(6):1168-1169.  volumes[J]. J Pediatr,2013,162(4):685-690.e1.
          [ 8 ]  SHINWELL E S,KARPLUS M,BADER D,et al. Neona‐  [19]  PELTONIEMI  O,KARI  M  A,HEINONEN  K,et  al.
               tologists are using much less dexamethasone[J]. Arch Dis   Pretreatment  cortisol  values  may  predict  responses  to
               Child Fetal Neonatal Ed,2003,88(5):F432-F433.       hydrocortisone administration for the prevention of bron‐
          [ 9 ]  DOYLE L W,CHEONG J L,EHRENKRANZ R A,et al.        chopulmonary dysplasia in high-risk infants[J]. J Pediatr,
               Early(<  8  days)systemic  postnatal  corticosteroids  for   2005,146(5):632-637.
               prevention  of  bronchopulmonary  dysplasia  in  preterm       [20]  PATEL R M. Short- and long-term outcomes for extremely
               infants[J].  Cochrane  Database  Syst  Rev,2017,10(10):  preterm infants[J]. Am J Perinatol,2016,33(3):318-328.
               CD001146.                                      [21]  JOBE A H,BANCALARI E. Bronchopulmonary dysplasia
          [10]  OFMAN  G,PEREZ  M,FARROW  K  N.  Early  low-dose   [J]. Am J Respir Crit Care Med,2001,163(7):1723-1729.
               hydrocortisone:is  the  neurodevelopment  affected? [J].  J   [22]  HIGGINS J P T,ALTMAN D G,GØTZSCHE P C,et al.
               Perinatol,2018,38(6):636-638.                       The  Cochrane  Collaboration’s  tool  for  assessing  risk  of
          [11]  WATTERBERG K L,GERDES J S,COLE C H,et al. Pro‐     bias in randomised trials[J]. BMJ,2011,343:d5928.
               phylaxis of early adrenal insufficiency to prevent broncho‐                      (下转第1261页)


          · 1256 ·    China Pharmacy  2023 Vol. 34  No. 10                            中国药房  2023年第34卷第10期
   109   110   111   112   113   114   115   116   117   118   119